Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dental pulp stem cells for severe lung contusion: intravenous versus intra-alveolar delivery
IRCT20101220005426N12Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Nov 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-blind trial of human dental pulp mesenchymal stem cells in Lung Contusion (3 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: PaO2/FiO2 ratio, ventilation duration and 5 more. Started Nov 2022; status: completed.
02
Drugs
human dental pulp mesenchymal stem cells
03
Conditions
Lung Contusion
Beyond the preview
Go deeper on IRCT20101220005426N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101220005426N12.